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INTRODUCTION1-4 
 It is traditionally defined as the right ventricular failure secondary 
to disorders that affect either the structure or function of the lungs. 
The association of heart failure with chest diseases was not 
recognised until the beginning of the 20th century. Osler did not mention 
it in his Text Book of Medicine published in 1904 but referred to it in 
later editions. 
The term cor pulmonale was first introduced into the medical 
literature by white (1931). Prior to that it was generally known as 
emphysema heart, pulmonary heart disease Ayerzas disease and rather 
eloquently as 'Black cardiacs'4. 
Different terms have been used by different workers, pulmonary 
failure (Fulton 1953), pulmonary hypertensive heart disease with arterial 
desaturation (Hecht, 1956), pulmonary heart failure (Stuart Harries and 
Henley, 1957), secondary pulmonary hypertensive cardiovascular disease 
(Meltingly, 1962) and chronic pulmonary hypertensive heart disease 
(Calland, 1963) are some of the terms used for the condition known today 
as cor puomonale. No satisfactory definition has been provided so far for 
this condition Strong in 1947 defined cor pulmonale as right ventricular 
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hypertrophy due to the disorder of pulmonary circulation from any 
cause.2, 4 
Fishman et al. (1960) believed that mere presence of pulmonary 
hypertension does not mean right ventricular disease. 
Stuart Harries and Henley (1957) used the term cor pulmonale only 
when congestive heart failure was present and proposed the name 
pulmonary heart failure to avoid ambiguous terminology. 
Friendberg (1956) defined cor polmonale as hypertension of the 
right ventricle with or without congestive heart failure resulting from 
diseases of the lung or of the pulmonary vascular tree. 
Ruben et al. (1961) defined cor puomonale as a cardiac 
enlargement in the form of dilatation or hypertrophy or both secondary to 
pulmonary diseases, bearing no relation to the presence of pulmonary 
hypertension. 
There is general agreement regarding exclusion of right ventricular 
involvement secondary to other forms of heart diseases like mitral 
stenosis and patent ductus arteriosus associated with pulmonary 
hypertension (Spain and Handler, 1948). 
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Evans (1964) however defined pulmonary heart diseases as 
resulting from any lung condition as well as direct involvement of the 
heart, such as suppurative pericarditis and granulomas like Hodgkin's 
disease and tuberculosis. 
Chronic cor pulmonale is recognised as a serious protracted, 
ultimately fatal human experience consuming frequently a large segment 
of the sufferer's life. 
As a sociological entity, every case has its etiological and 
aggravating environmental factors and its many economic implication. 
This disease, in areas where it is prevalent thus constitutes a serious 
problem in public health and preventive medicine.3, 4 
This disease has remained unrecognised so long due probably to a 
number of causes. For many years the diagnosis was not made. The 
condition was obscured by the accompanying pulmonary manifestations 
on one hand, and was identified on the other hand as some other form of 
heart disease. It is only recently that the clinical physiologists have 
worked out physiological relationships between chronic pulmonary 
disease and cor pulmonale and still more recently that adequate methods 
of diagnosis have been established. Physiologists have now simplified the 
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principles and methods of diagnosis so that physicians can add them to 
their clinical analysis.1,2 
The wide disparities in the reported incidence of the disease in 
different areas many simply reflect these inconsistencies in the diagnostic 
terminology and conventions. On the other hand, these reports do indicate 
real variations in disease experience and may give important clues to 
those differences in local environment or ways of life, which may 
underlie the geographical distribution of the disease.5 
Chronic cor pulmonale can be diagnosed clinically, radiologically, 
electrocardiographically, by Echocardiography and also by invasive 
techniques. 
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AIMS AND OBJECTIVES 
 Aim of the study is to 
1. Identify the probable causes and the primary lung disease, which 
lead to chronic cor pulmonale. 
2. Study the clinical profile including Electrocardiographic and 
Radiological features. 
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REVIEW OF LITERATURE 
DEFINITION3,5-7, 9 
 Definitions of chronic cor puomonale have been put forward by 
many authors in clinical, functional or morbid anatomical terms. A 
clinical definition is considered unsatisfactory, since the chief clinical 
manifestation is heart failure, which takes a long time to develop. 
 A functional definition in terms of pulmonary hypertension or 
raised pulmonary vascular resistance is difficult to measure and is 
variable, and hypertension may be evanescent, may only occur on 
exercise and may decline in the terminal phase of the disease. 
 The WHO committee therefore prefers a definition based upon 
morbid anatomy, for this provides the only characteristic common to all 
patients at all stages of the disease.5 
 The definition of cor pulmonale is now fairly universally accepted 
as 'alteration in structure and function of the right ventricle resulting from 
diseases affecting the structure and function of the lung or its vasculature. 
This specifically excludes the alterations resulting from diseases of the 
left ventricle or congenital heart disease.9 
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 Chronic Cor Pulmonale is characterized by hypertrophy and 
dilatation of the right ventricle secondary to the pulmonary hypertension 
caused by disease of the pulmonary parenchyma and / or pulmonary 
vascular system between the origins of the main pulmonary artery and the 
entry of the pulmonary veins into the left atrium.3 
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ETIOLOGY AND CLASSIFICATION4, 5 
1. Etiological Classification 
 The WHO has given the following classification of cor pulmonale 
according to the diseases, which produce secondary right ventricular 
hypertrophy. 
I. Diseases primarily affecting air passages of the lung and the 
alveoli. 
1. Chronic bronchitis with generalized airways obstruction with or 
without emphysema. 
2. Bronchial asthma 
3. Emphysema without bronchitis or asthma 
4. Pulmonary fibrosis, with or without emphysema due to: 
a. Tuberculosis 
b. Pneumoconiosis 
c. Bronchiectasis 
d. Other pulmonary infections 
e. Muco viscidosis 
  9
5. Pulmonary granulomata and infiltration 
a. Sarcoidosis 
b. Chronic diffuse interstitial fibrosis 
c. Berylliosis 
d. Eosinophilic granuloma or histiocytosis 
e. Malignant infiltration 
f. Scleroderma 
g. Dermatomyositis 
h. Disseminated lupus erythematosus  
i. Alveolar resection 
6. Pulmonary resection 
7. Congenital cystic disease of the lungs. 
8. High attitude hypoxia 
II. Disease primarily affecting the movements of the thoracic cage 
1. Kyphoscoliosis and other thoracic deformities. 
2. Thoracoplasty 
3. Pleural fibrosis 
4. Chronic neuromuscular weakness e.g. Poliomyelitis. 
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5. Obesity with alveolar hypoventilation. 
6. Idiopathic alveolar hypoventilation 
III. Disease primarily affecting the pulmonary vasculature 
1. Primary affections of arterial wall. 
a. Primary pulmonary hypertension. 
b. Poly arteritis nodosa 
c. Other arterities 
2. Thrombotic disorder. 
a. Primary pulmonary thrombosis 
b. Sickle cell anaemia 
3. Embolism 
a. Embolism from thrombosis out side the lungs 
b. Schistosomiasis 
c. Malignant embolism 
d. Other embolism 
4. Pressure on main pulmonary arteries and veins by mediastinal 
tumours, aneurysm, granuloma or fibrosis. 
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2. Clinical classification of cor pulmonale 4, 5 
 Clinically cor pulmonale is classified into acute, subacute and 
chronic depending on the onset of the disease. 
 Acute cor pulmonale is sudden in onset and it follows massive 
pulmonary embolism. 
 The subacute variety may range from days to weeks. It is seen in 
patients with repeated bouts of small pulmonary embolism or 
endolymphatic carcinomatosis. 
 Chronic type may take a few months to year for its development 
and it commonly occurs in association with chronic pulmonary disease. 
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PRE  DISPOSING FACTORS3, 7, 8, 10-13 
1. AGE 
 As chronic obstructive pulmonary diseases are common in middle 
and elderly age groups, the incidence of cor pulmonale is more common 
between 4th to 6th decade7. 
2. SEX 
 The disease is more prevalent in males. The most probable cause is 
high incidence of smoking in males. 
3. TOBACCO SMOKING 
 Smoking is the most commonly identified correlate with cor 
pulmonale. It was found that mortality rate for chronic bronchitis was 
significantly higher in cigarette smokers than in non smokers and 
increased with the amount smoked. In those who stopped smoking, which 
would include many who stopped for medical reasons, the mortality at 
first rose but by 10 years was well below that for smokers. 
 Sample surveys of respiratory symptoms in the population have 
shown a much higher prevalence of cough and sputum among smokers. 
In such surveys, chronic bronchitis, whatever the definition used, has 
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been almost always confined to smokers. For example, a sample survey 
in urban and rural population in Britain found in males aged 55 to 64 that 
the prevalence of chronic bronchitis was 17.6% in heavy smokers, 13.9% 
in light smokers, 4.4% in ex-smokers and nil among non smokers, similar 
differences were found in the Royal College of General Practitioners 
survey.11 
 Prevalence studies in at least 10 countries have confirmed the 
relationship between smoking and chronic bronchitis. A number of these 
surveys have included simple tests of respiratory function as FEV1 and 
PEFR. On the whole, the tests indicated poorer function in smokers than 
in non smokers. Follow up studies have shown a steeper decline in FEV1 
among smokers than among ex smokers or non smokers and rapid 
slowing of the rate of decline following cessation of smoking. Diffusing 
capacity is also decreased in smokers10. 
 The effects of cigarette smoke may begin at an early age, as 
indicated by increased respiratory illness and diminished pulmonary 
function in children passively exposed to parental cigarette smoke. 
 Cigarette smoking causes airway obstruction by mucosal gland 
hypertrophy with resulting increased mucus secretion, coupled with the 
inhibitory effects on the bronchial ciliary blanket, which predisposes to 
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the accumulation of mucus in the bronchial tree. Superimposed infection 
with associated mucosal edema and infiltration with inflammatory cells 
will exacerbate airways obstruction. 
 The effect of smoking may be irritant receptor reflex induced 
phenomenon. 
 Finally cigarette smoking recruits inflammatory cells to the lungs 
as indicated by increased numbers of neutrophils and macrophages in 
bronchoalveolar lavage fluid from smokers' lungs. 
 Cigarette smoke can stimulate alveolar macrophages to release 
neutrophil chemo attractants and smoke can also cause elastase release 
from neutrophils. In addition cigarette smoking can inactivate alpha 
antitrypsin probably by oxidation, and indeed a diminution of functional 
alpha antitrypsin in by about 50% has been demonstrated in 
bronchoalveolar lavage fluids of human smokers. Local inactivation of 
alpha antitrypsin may also result from the release of oxidants from 
activated neutrophils and macrophages. In smokers therefore, the scene of 
protease antiprotease imbalance is well set and it seems likely that this is 
the cause of emphysema found in association with chronic bronchitis. 
The emphysema itself, with its loss of supporting lung substance is a 
major contributor to airway obstruction and cor pulmonale.3 
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4. ATMOSPHERIC POLLUTION4, 12 
 The effect to pollution can begin early in life. An acute form of 
respiratory distress resembling acute bronchitis and often continuing into 
a chronic form with predominant wheeze has been described in 
individuals. 
Smoke may be the most important pollutant. The two great London 
Smogs of 1952 and 1962 were both associated with a rise in bronchitis 
mortality much higher in 1952 than 1962. The sulphuric oxide 
concentrations were similar in both years but the smoke concentration 
was much lower in 1962 and so was the associated respiratory mortality. 
Exacerbation of bronchitis is clearly related to periods of heavy 
pollution with sulphur dioxide. Nitrogen dioxide can produce small 
airway obstruction in experimental animals exposed to high concentration 
of nitrogen dioxide. 
5. OCCUPATION10, 12  
 Chronic obstructive lung diseases are more prevalent in workers 
who are engaged in occupations exposing them to either inorganic or 
organic dusts or to noxious gases. Epidemiologic surveys have succeeded 
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in demonstrating accelerated decline in lung function of many such 
workers. 
6. INFECTION1, 2, 13 
 Katten et al. have demonstrated evidence of small airways 
dysfunction 10 years after an attack of bronchiolitis in infancy, having as 
far as possible excluded asthmatics. 
 In a community study in Arizona, Lebowitz and Burrows found a 
highly significant correlation between poor respiratory function and a 
history of childhood respiratory illness or of recurrent respiratory 
infections in adult life. It makes an even bigger contribution to the 
development of chronic lung disease in developing countries with poor 
social conditions and poor medical services. 
 Earlier pathological studies, very reasonably showed that each of 
the infective exacerbation produced a little further lung damage and 
added a little more to the permanent impairment of respiratory function. 
A number of studies have also shown a correlation between deterioration 
of lung function and frequency of exacerbation. 
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 The viruses concerned were those causing respiratory infection in 
the general population and included influenza, parainfluenza and 
respiratory syncitial viruses. 
 Mycoplasma pneumoniae infection has been reported in 
association with exacerbation of chronic bronchitis in a small number of 
cases. 
 Bacterial infection with encapsulated strains of hemophilus 
influenza or with streptococcus pneumoniae plays a major part in 
exacerbations of chronic bronchitis associated with pus in the sputum, 
though these infections may only be a complication of an exacerbation 
initiated by a viral infection. More recently Branhamella catarrhalis has 
been implicated in exacerbations of chronic bronchitis. 
 Hemophilus and streptococcus pneumoniae are more frequently 
isolated from mucopurulent than from mucoid sputum in chronic 
bronchitis. They are frequently present in the nasopharynx of normal 
people but tend to spread into the lower respiratory tract in the winter 
after an upper respiratory tract infection. 
 It is not necessary that all exacerbations are infective in origin. In 
two Edinburgh studies pathogens were identified in only about half of the 
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cases. Some may be largely chemical or irritative in origin even though 
secondary infection is common. 
7. GENETIC FACTORS14 
 Alpha–1 antitrypsin deficiency: Eriksson established that this 
deficiency is inherited and associated with development of lung disease in 
early adulthood. 
 Genetic variations in human β - defesin an endogenous 
antimicrobial peptide in the airway has also been found to be significantly 
associated with development of COPD where the component of chronic 
bronchitis is predominant.14  
8. IMMUNOLOGICAL FACTORS 
 In 1970 Dutch workers proposed that individuals with asthma and 
smokers with chronic irreversible airflow obstruction shared a common 
allergic constitution and increased non specific bronchial reactivity. 
 Numerous workers have found that smokers have higher IgE levels 
and higher eosinophil counts than non smokers although the levels do not 
approach those seen in asthmatics. Atopic status does not appear to differ 
between smokers and nonsmokers. 
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 It is interesting that histamine, SRS-4 and IgE can be demonstrated 
in significant levels in bronchitic sputum and that there is a significant 
inverse correlation between these levels and the minor variations in 
PEFP. 
 It remains possible that mediators of type I hypersensitivity may 
make a small but nevertheless significant contribution to the 
pathophysiology of cor pulmonale. 
 Tumour Necrosis Factor α a potent pro-inflammatory cytokine 
may be associated with development of COPD. Polymorphisms of TNF - 
α gene promoter is also found be associated with COPD.15  
9. ABNORMALITIES OF THORACIC CAGE17 
 Scoliosis: In scoliosis the total lung volume is reduced and the 
lungs differ in size with distortion of lobar shape due to deformity. 
Alveolar size may vary, and if scoliosis has been present from an early 
age alveolar numbers per acinus may correspond to the developmental 
stage. In severe scoliosis progressing to cor pulmonale the pulmonary 
changes associated with marked vascular medial hypertrophy are 
indistinguishable from the changes seen in other causes of cor pulmonale. 
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 Lung volumes are reduced with a restrictive pattern even in 
asymptomatic adolescents with scoliosis. 
 The higher the dorsal spine curve, the more severe is its effect on 
function. 
 The residual volume may be maintained by increasing RV/TLC 
ratio. The FEV1/FVC ratio is normal unless obstructive disease 
supervenes. 
 Lung compliance in scoliosis is commonly low, perhaps reflecting 
occurrence of small airway collapse due to inability to take deep breath or 
a sigh. 
 In patients with mid or high thoracic curve greater than about 100°, 
progression to pulmonary hypertension with or without right ventricular 
failure often occurs in fourth decade. 
 Pectus excavatum or funnel chest: In this condition, the body of 
the sternum is angled backwards towards the spine. Minor decreases in 
vital capacity, total lung capacity and maximal breathing capacity have 
been reported. 
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10. OTHER RARE CAUSES16 
 Some rare causes have been reported where corpulmonale occurred 
secondary to muscle weakness. A case was reported where a 46 year old 
female admitted for decompensated corpulmonale was found to have 
metabolic myopathy due to acid maltase deficiency as the primary cause.  
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PHYSIOLOGICAL DERANGEMENTS IN CHRONIC 
COR PULMONALE17-19 
 The physiological disturbances in this group of diseases comprise 
those related to the respiratory function (gaseous exchange) and those 
connected with the hemodynamics of the pulmonary circulation. Though 
individual diseases can be classified broadly according to predominant 
physiological disturbances, it must be recognised that these frequently 
over lap and are present to a variable extent at different stages of the 
diseases. 
Disturbances in the respiratory function: 
 The alterations in the respiratory function that can be recognised 
are four in number. 
1. Obstructive ventilatory impairment: 
  Impairment due to obstruction to airflow somewhere within the 
tracheobronchial tree. 
2. Restrictive ventilatory impairment: 
 Impairment due to reduction of ventilatory capacity without 
obstruction to airflow. 
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3. Impairment in pulmonary gas diffusion: 
 Disturbance in gaseous exchange between alveoli and pulmonary 
capillary due to anatomical or functional alterations. 
4. Reduction in the ventilation perfusion ratio: 
 This implies that some of the blood traversing the lungs passes 
through areas of diminished or absent ventilation or through 
arteriovenous pulmonary shunts. 
 The final effect of these functional alterations is seen by reference 
to the arterial blood and to the respective tensions there in of O2 and CO2. 
The interactions in various alteration in function may be seen by 
reference to the following examples. 
 In chronic bronchitis with emphysema the main disturbance is that 
of obstructed ventilation but this may be accompanied by various degrees 
of impairment of the pulmonary gas diffusion and by reduction in the 
ventilation perfusion ratio. 
 In severe pulmonary fibrosis the main disturbance is one of the 
restricted ventilation but this may be accompanied by reduction in 
pulmonary gas diffusion and in the ventilation perfusion ratio. 
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PATHOGENESIS9,20,23 
 Pulmonary hypertension is the "sine qua non" of cor pulmonale. 
Accordingly, the mechanisms of cor pulmonale are first those of 
pulmonary hypertension. In chronic respiratory diseases pulmonary 
hypertension results from increased pulmonary vascular resistance (PVR) 
whereas cardiac output and pulmonary "capillary" wedge pressure are 
normal; pulmonary hypertension is said to be precapillary.  
 The factors leading to an increased PVR in chronic respiratory 
disease are numerous but alveolar hypoxia is by far the most 
predominant, at least in COPD, kyphoscoliosis, and the obesity – 
hypoventilation syndrome. Two distinct mechanisms of action of alveolar 
hypoxia must be considered. Acute hypoxia causes pulmonary 
vasoconstriction, and chronic longstanding hypoxia induces structural 
changes in the pulmonary vascular bed (pulmonary vascular 
remodelling).  
 Hypoxic pulmonary vasoconstriction (HPV) has been known since 
the studies in 1946 of Von Euler and Liljestrand on the cat. HPV explains 
the rise of PVR and PAP observed in humans, and in almost all species of 
mammals, during acute hypoxia. The vasoconstriction is localised in the 
small precapillary arteries. Its precise mechanism is not fully understood. 
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The clinical situations that bear the closest analogy with acute hypoxic 
challenges are probably exacerbations of COPD leading to acute 
respiratory failure, and the sleep related episodes of worsening 
hypoxaemia.  
 Furthermore, other functional factors must be considered, namely 
hypercapnic acidosis and hyperviscosity caused by polycythaemia, but 
their role seems small when compared to that of alveolar hypoxia. In 
idiopathic pulmonary fibrosis the increase of PVR is caused by 
anatomical factors: loss of pulmonary vascular bed or compression of 
arterioles and capillaries by the fibrosing process.  
 Pulmonary hypertension increases the work of the right ventricle, 
which leads more or less rapidly to right ventricular enlargement 
(associating hypertrophy and dilatation) which can result in ventricular 
dysfunction (systolic, diastolic). Later, right heart failure (RHF) 
characterised by the presence of peripheral oedema can be observed, at 
least in some respiratory patients. The interval between the onset of 
pulmonary hypertension and the appearance of RHF is not known and 
may vary from one patient to another. There is a relation between the 
severity of pulmonary hypertension and the development of RHF.  
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HEMODYNAMIC FEATURES4, 24 - 26 
 The hemodynamic observations in cor pulmonale depend 
somewhat on the cause and duration of lung disease. In patients with 
multiple pulmonary emboli or primary pulmonary hypertension, 
pulmonary arterial pressures are more apt to reach systemic levels than 
are seen in patients with chronic bronchitis and emphysema during an 
acute respiratory infection. Patients with diffuse interstitial disease tend to 
have moderate levels of pulmonary arterial hypertension until late in the 
disease, when ventilation perfusion abnormalities become sufficiently 
deranged to cause arterial hypoxaemia and respiratory acidosis. 
 Mean pulmonary arterial pressures may then reach 60 to 80 mmHg. 
The cardiac output tends to be normal at rest, except late in the disease, 
when it is apt to be low. In instances of cor pulmonale in which 
hypoxaemia is a prominent feature, cardiac output tends to be at upper 
normal limits or slightly greater than normal, recovery from heart failure 
is associated with a decrease in cardiac output towards normal, 
presumably as a consequence of the relief of hypoxaemia and acidosis. 
During exercise, the increase in cardiac output restricted pulmonary 
vascular tree, particularly if associated with arterial hypoxaemia, 
generally elicits large increments in pulmonary arterial pressure. 
 The left atrial pressure is almost consistently normal in cor 
pulmonale. Exceptions may occur in any type of heart failure that is 
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associated with an increase in circulating blood volume or, more 
specifically, when cor pulmonale is complicated by left ventricular 
failure. Pulmonary hypertension being the common denominator in all 
types of cor pulmonale, may lead to right ventricular failure. Particular 
hemodynamic features characterize different stages in this sequence. 
Thus, before the stage of cor pulmonale, the cardiac output is normal at 
rest and increases normally during exercise; the filling pressures of the 
right ventricle (end diastolic pressures) remain normal. Though levels of 
pulmonary hypertension may vary according to the cardiac output and 
level of hypoxaemia. 
 The next stage of cor pulmonale, is characterised by abnormally 
high filling pressures to accomplish normal increments in cardiac output. 
Pulmonary arterial pressures may then increase considerably or remain 
unchanged, depending on the increase in cardiac output and degree of 
arterial hypoxemia. Finally, should the right ventricle fail, end diastolic 
pressures in the right ventricle become abnormally high, and the cardiac 
output which may be normal at rest, fails to increase normally during 
exercise. At this time, systemic venous congestion manifest, and the 
circulating plasma volume increases as in other types of heart failure. 
Lung water also increases. 
 Both circulating plasma volume and lung water decrease as right 
ventricular failure and systemic venous congestion are relieved. 
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CLINICAL FEATURES OF COR PULMONALE4, 6, 27, 28 
Clinical recognition of cor pulmonale: 
 All too often the clinical diagnosis of cor pulmonale is first 
entertained only after the right heart has failed and has evolved systemic 
venous hypertension, congestive hepatomegaly and peripheral edema. 
Indeed, many clinicians continue erroneously to reserve the diagnosis of 
cor puomonale until the stage of right ventricular failure has materialized. 
 The diagnosis of cor pulmonale is liable to be overlooked unless 
each patient with pulmonary abnormalities that predispose to pulmonary 
hypertension is regarded as a likely candidate and clinical acuman is 
directed towards uncovering early signs of right ventricular enlargement. 
 Some predisposing conditions are easier to recognise than others. 
 It is possible to think of COPD as a continum, with chronic 
bronchitis at one extreme and emphysema at the other end and the 
majority of patients having features of both conditions. 
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The distinction between the two groups is presented in the 
following table. 
Comparison of clinical and physiological features of emphysema and 
chronic bronchitis 
 Emphysema Chronic bronchitis 
Signs and symptoms:   
Cough and sputum Scanty Marked  
Dyspnoea at rest Marked Usually absent 
Recurrent chest infections Unusual Frequent 
Cyanosis No Yes 
Edema No Yes 
Increase AP diameter of thorax Marked Mild 
Hyperresonance to percussion Marked Mild 
Breath sounds Absent to depressed Rales, rhonchi 
Hyper inflation  No hyperinflation  
Chest X-ray 
No cardiomegaly Cardiomegaly 
Pulmonary Gas Exchange:   
Haematocrit Normal Elevated 
Pa O2 Slight reduction Markedly reduced 
Pa Co2 Low or normal Elevated 
Diffusing capacity Markedly decreased Normal or rest 
Pulmonary mechanisms   
Expiratory flow rate Reduced Reduced 
Elastic recoil Markedly reduced Normal or slightly 
reduced 
Lung volume Marked 
hyperinflation 
Mild hyperinflation 
Pulmonary circulation   
Pulmonary hypertension at rest None or mild Marked 
With exercise Moderate Marked 
Rt. Heart failure Terminal Repeated 
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CLINICAL MANIFESTATIONS OF COR PULMONALE 
WITH HEART FAILURE 
The presenting symptoms include 
1. Dyspnoea 
2. Paroxysmal cough 
3. Fluid retention with edema and sometimes ascites 
Most commonly observed findings are 
1. Central cyanosis 
2. Distended neck veins which exhibit prominent 'a' and 'v' waves 
and do not collapse with inspiration. 
3. Palpable parasternal or subxiphoid heave 
4. Loud pulmonic second sound 
5. S3 gallop on right side accentuated by inspiration 
6. Holo systolic murmur along the lower left parasternal edge 
accentuated by inspiration 
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7. Examination of lung reveals diffuse inspiratory and expiratory 
rhonchi. 
8. Liver is enlarged, tender and frequently pulsatile 
9. In acute respiratory failure papilledema, confusion, hyperkinetic 
circulation and asterexis may be present. 
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ELECTROCARDIOGRAPHY29 –34 ,36-39 
 Electrocardiography is quite essential in the diagnosis of 
pulmonary heart disease and in following its course.  
 The ECG findings suggestive of cardiac involvement in chronic 
pulmonary disease can be best understood if they are divided in the 
following groups.  
a) ECG findings in right ventricular hypertrophy without any 
associated emphysema.  
b) ECG findings when right ventricular hypertrophy is associated 
with emphysema.  
c) ECG findings that are purely due to emphysema without any right 
ventricular hypertrophy.  
d) ECG findings that may mimic coronary artery disease, which may 
be due to emphysema and/or cor pulmonale as proved at autopsy. 
Before dealing with these specific problems some relevant points 
in this connection are worth mentioning.  
 Right ventricular hypertrophy may be due to increased volume load 
or due to increased pressure load.  
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 In increased volume load the crista supraventricularis shows 
hypertrophy, the free right ventricular wall may be normal. In the ECG 
this is seen as rsR' in V1. In case of increased pressure load hypertrophy 
of the entire right ventricular wall and of the crista superaventricularis is 
seen. Here in addition to a dominant R in V1 there is wide S in I, II, III, 
V5, V6. 
 In cor pulmonale the hypertrophy of the right ventricle is due to 
both the pressure and the volume overload, more so the former as it 
occurs chiefly as a result of pulmonary hypertension.  
 However, rarely hypertrophy may be due primarily to a volume 
load as shown by the hypertrophy of the crista superventricularis with the 
involement of the free right ventricular wall.34 Much of the prevailing 
confusion regarding the ECG in corpulmonale can be minimised if it can 
be remembered that about one third of the cases show pathognomic 
findings one third only suggestive findings, while in remaining one third 
of the cases the ECG tracings either are normal or show mild nonspecific 
changes.32 
 Philips and Previdence (1958) described the evolution of ECG 
changes in RVH as follows. The normal cardiac vector is directed to the 
left and posteriorly. This is due to the greater weight and thickness of the 
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left ventricle which is two to three times greater than that of right 
ventricle. Until the resultant vector remains directed to the left and 
posteriorly (due to the left ventricular preponderance) there will be no 
change in the ECG tracing no matter to what extent the hypertrophy of 
right ventricle has taken place. This has been described as stage I.33 
 In stage II when considerable hypertrophy of right ventricle has 
already occured the resultant vector now moves to the right but still it is 
directed to posteriorly due to greater mass of the left ventricle. This 
produces a left axis deviation in frontal plane and prominent 'S' wave 
appears in the left sided precardial leads (V4-V6).  
 In third and final stage the Electro motive force is directed out not 
only to the right but also anteriorly for by now a markedly hypertrophied 
right ventricle occupies an extremely anterior position. The patients in 
this category have the heaviest hearts with the thickened right ventricular 
walls.34 
 The ECG in these patients showed a tall R wave in the right sided 
precardial leads including V3 R and V4 R.29 However at this stage it is to 
be recollected that not only is the right ventricle becoming hypertrophied 
during all stages but the left ventricle is also expanding its dimensions at 
least in one third of the cases of cor pulmonale.  
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 So the ratio of right ventricular and left ventricular thickness or 
weight along with the displacement and rotational changes in the two 
chambers will be responsible for the changes seen in the serial 
electrocardiograms. This explain why even in fatal cases of 
decompensated cor pulmonale showing definite right ventricular 
hypertrophy at autopsy the ECG may be entirely normal Similarly even 
marked enlargement of the right ventricle may not be obvious in ECG 
tracings in the  presence of left ventricular hypertrophy or left ventricular 
conduction defects.31 
 Some of the commonly used criteria for right ventricular 
hypertrophy include those of Mayor et al (1948) Sokolow and Lyon 
(1949) Gold Berger (1953) Scott et al (1955) and Milnor (1957) (1957) 
Every criteria suggested for ECG diagnosis of RVH has its own merit, 
but availability of so many criteria itself is a proof of their inadequacy. 
The criteria adopted by Sokolow and Lyon (1949) which gives highest 
number of positive results indicative of RVH in ECG also gives the 
highest number of false positives. Goldberger criteria has shown 68.7% 
reliability and 6.3% false positive. While Mayer et al criteria gave 50% 
reliability and only 3.1% false positive.  
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 Sokolow (1949) believed that the best criteria of RVH are,  
 1. Shift of the mean QRS axis to the right  
 2. An R : S ratio in lead V1 greater than 1 
 3. R : S ratio in lead V6 of less than 1. 
 Despite these criteria correlation of autopsy and ECG changes of 
cor pulmonale are poor. The reason may be due to part to the altered 
spatial orientation of the heart within the thorax.34  
 In addition there are other conditions that may make ECG 
diagnosis difficult for example:  
1. Presence of either combined ventricular hypertrophy or right 
ventricular hypertrophy associated with LBBB. 
2. Posterior myocardial infarction with its loss of terminal vectors 
from the posterior aspect of the left ventricle may resemble the 
ECG as seen in pulmonary heart disease.  
3. In cor pulmonale the evidence of RVH are masked or modified by 
the presence of emphysema so that there is considerable decrease 
in the sensitivity and specificity of various criteria.  
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ECG changes in RVH without emphysema  
1. Dominant R in V1 or V3 R, 'R' exceeding 7 mm in height and 
pattern may be 'R',  'RS', qR, QR, RS, and rSR.  
2. RS ratio in V1 greater than 1 with 'S' in V1 not more than 2 mm.  
3. R in V5 – V6 less than 3 mm with 'S' in V5, V6 more than 7 mm 
and R : S ratio is less than one.  
4. ST segment depression with T wave inversion in V1, V2, V3.  
5. Incomplete RBBB pattern and R greater than 10mm in VI.  
6. Intrinsicoid deflection and ventricular activation time of 0.035 secs 
or more in V1, V2.  
7. Sum of R in V1 + S in V5 or V6 are more than 10 mm. 
8. Clockwise rotation of heart with right axis deviation.  
9. Depression of ST segment with T wave inversion in I, II, III AVF.  
10. Wide S in leads, I, II, III with R : S ratio less than one in leads I, II, 
III (involvement of crista supraventricularis).  
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11. Tall and Peaked 'P' waves in leads II, III aVF, height exceeding 2.5 
mm with axis more than + 600. 
12. QR, qR pattern in aVR with R more than 5 mm and R : Q ratio 
more than one.  
13. Typical Specific S1, Q3, T3 pattern may be seen specifically in 
acute cor pulmonale.  
14. With marked right atrial dilation Q wave appear in right sided 
precardial leads.  
ECG in emphysema: 
 Pulmonary emphysema commonly produces changes in the ECG 
which are secondary to the hyperinflation of the lungs and which need not 
indicate associated RVH or strain.  
1. Low voltage: Low voltage is defined as a total RS magnitude that 
does not exceed 5mm in any of the frontal leads and 10 mm in any 
of precardial leads. Since air is a relatively poor conductor of 
electricity it is understable that the hyperinflated lungs will reduce 
the electrical potential of the heart as recorded on body surface.  
2. The frontal plane QRS axis may be between + 900 and + 1100 
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3. The terminal QRS forces in the frontal plane may be directed right 
ward (producing an S wave in I) and superiorly (producing S wave 
in II, III and aVF). This has been known as S1, S2, and S3 
syndrome. The cause for this is not known. Although it is seen in 
patients with emphysema, it is also seen as a normal variant in 
children and young adults.  
4. An incomplete (or complete) RBBB may be a mainfestation of 
right ventricular strain.  
5. QS waves may be recorded in anterior chest leads.  
6. Posterior rotation of heart, which may produce Q in II, III, and 
aVF. 
ECG findings when right ventricular hypertrophy is associated with 
emphysema 
 Since in chronic cor pulmonale there is varying degree of 
emphysema and hypertrophy of right ventricle the following may be 
taken as,  
Early decisive: 
1. Rt. axis deviation of 1100 or more 
2. Wide S in lead I, II, III with R : S ratio < 1 in I, II, III 
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3. Incomplete RBBB with R in VI < 10 mm  
4. qR in V1, V3R or QS pattern in V1, V2, V3 aVF like an 
anteroseptal infarction.  
5. P pulmonale in leads II, III a VF and axis greater than 600.  
Fairly suggestive: 
1. Complete RBBB with R in V1, greater than 15 mm 
2. S in V5, V6 ,more than 10 mm  
3. S in V1 less than 5 mm with R in V1 + S in V5 more than 10 mm 
4. Right axis deviation from + 750 to + 1100 
5. qR or QR in aVR with R more than 5mm and R : Q ratio more than 
one or QR less, than one 
6. low voltage complex with clockwise rotation with vertical heart 
7. Ventricular activation time of more than 0.0355 with ST 
depression in right sided precordial leads.  
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ECG findings simulating coronary artery disease: 
 The various electrocardiographic findings that can simulate 
mycordial ischemia or old infarction are: 
1. Presence of QS pattern either in right sided precardial leads or in 
all routine precardial leads in the absence of old anteroseptal or 
anterior wall infarction.  
2. Presence of QS complex in aVL due to vertical position of the 
heart in frontal plane.  
3. ST depression and or T wave inversion in leads II, III, aVF and 
from  
V1 to V6. 
 Though cardiac arrhythmia's and various conduction defects are 
quite uncommon in cor pulmonale as compared with primary disease of 
heart, in case they are present, they can create many problems in the 
interpretation of the ECG tracing of cor pulmonale.  
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RADIOLOGICAL FINDINGS IN CHRONIC COR 
PULMONALE40 – 43 
 Chest roentgenograms including PA; lateral view are most valuable 
tools for identifying cor pulmonale. In selected  cases fluoroscopy, 
bronchography, pulmonary angiography, computed tomography (CT) and 
other radiographic procedures may provide useful information. 
 In cases of emphysema the low position of diaphragm, elongates 
the heart and makes it appear relatively smaller, inspite of its actual 
enlargement. It is worth remembering, that the right ventricle when it 
hypertrophies enlarges first anteriorly.  Hence,  obliteration of normal 
retrosternal space and bulging of the pulmonary arterial flow tract, are the 
earliest sign of right ventricular enlargement. This cannot be made out in 
the routine PA films. Lateral and right anterior oblique views are more 
valuable. Apical rib crowding may be seen or there may be widening of 
the rib spaces with elevation of clavicles. 
 The x-ray may also reveal the underlying lesions such as 
pulmonary tuberculosis, diffuse carcinomatosis and diseases causing 
interstitial pulmonary fibrosis, pneumoconiosis, bronchiectasis etc. 
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 The lack of cardiac enlargement in severe emphysema observed by 
Alexander (1927) was confirmed by Parkinson and Hyle (1937) who 
noted the prominence of the main pulmonary artery and dilation of main 
branches at the hilum in over 50% of their patients. In proved instances of 
cor pulmonale, however the size and shape of the heart shadow vary 
considerably depending upon the degree of the pulmonary vascular 
resistance or the absence of heart failure. 
 The earliest abnormal change is the enlargement of the main 
pulmonary artery and its branches. Diffuse obstructive emphysema 
usually causes specific changes in the position of the heart, the heart 
becoming more vertical and rotated in a clockwise direction about its 
longitudinal axis. Such positional changes will make the pulmonary 
artery segment appear slightly more prominent than usual in the both the 
postero-anterior and right anterior oblique views. In borderline cases, 
therefore it is sometime difficult to differentiate this increased 
prominence due to rotation of the heart from that due to slight dilatation 
of the pulmonary artery. In pectus excavatum and in fibrotic diseases 
contraction of the left upper lobe of the lung and bulging of the left 
middle segment often appears like pulmonary artery dilatation and should 
also be distinguished from that caused by true pulmonary artery 
dilatation. With the onset of heart failure, the transverse diameter of the 
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heart is usually increased and dilatation of the right atrium becomes 
obvious. When there is considerable fusiform dilatation of right 
pulmonary artery the radiological appearances may strongly suggest a 
bronchial carcinoma. However the associated dilatation of main 
pulmonary artery and its left branch which is almost always present 
should point to the correct diagnosis. When there is associated heart 
disease involving the left ventricle, cor pulmonale may be present with 
the clinical and radiological features of left ventricular failure. Pulsation 
of the right and left main branches of the pulmonary artery may be quite 
conspicuous on fluoroscopy but it is never florid as in atrial septal defect. 
Pleural effusion is very uncommon even in heart failure. 
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MATERIALS AND METHODS 
 
PLACE OF STUDY: Institute of internal medicine, GGH, MMC.  
STUDY DESIGN: Observational Study 
ETHICAL COMMITEE CLEARANCE: Obtained 
PERIOD OF STUDY: Dec 2007 to June 2008 
SELECTION CRITERIA: Presence of right ventricular hypertrophy 
and / or dilatation as observed by Echocardiography along with absence 
of underlying heart disease (eg Rheumatic, congenital, coronary heart 
disease)   which could have led to right ventricular failure.  
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STUDY POPULATION 
 The subjects for the study were selected from cases admitted to the 
medical wards of Government General Hospital, Chennai during the 
period from December 2007 to June 2008 who fitted in the criteria 
described above. The diagnosis of chronic cor pulmonale was made on 
the basis of history, physical findings and echocardiographic features.  
STUDY DESIGN: Observational study 
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METHODOLOGY 
 50 representative cases of chronic cor pulmonale which fitted in the 
criteria were selected. A detailed history was obtained from them and 
symptom analysis was done. A detailed clinical examination was also 
done.  
 A 12 lead electrocardiogram which included right sided chest leads 
V3 R and V4 R was obtained and analysed.  
 A chest radiograph which comprised of a posteoanterior chest film 
was obtained. In selected cases computerised tomogram of the chest was 
done. Parenchymal lesions in the lung were looked for which would give 
a clue to the underlying lung disease which caused chronic cor 
pulmonale. Presence of pulmonary artery dilatation and other features 
suggestive of cor pulmonale  were also looked for.  
 The clinical profile along with the probable etiology, radiological 
and electrocardiographic findings were summarised and compared with 
existing data.  
COMPETING INTEREST: NIL 
FINANCIAL SUPPORT: NIL 
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OBSERVATIONS 
 Out of these 50 patients 40 were male patients and 10 were 
females. The age of patients ranged from 35 to 80 years.  
AGE: 
 In our present study the following age distribution was observed. 
 The distribution showes that the peak incidence was in the 5th and 
6th decades.  
 Age distribution in shown in the table below.  
Table – 1  
AGE DISTRIBUTION 
Age groups (in Years) Number of cases Percentage 
<40 Years 8 16% 
40 – 50 12 24% 
51-60 20 40% 
>60 years 10 20% 
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SEX: 
 In our study 40 patients were males and 10 patients were females.  
Table – 2  
SEX DISTRIBUTION 
Sex Number of cases Percentage 
Male 40 80% 
Female 10 20% 
 
SMOKING HABITS: 
 
 In our study 38 male patients were smokers and used to smoke 
more than 10  cigarettes or beedies per day (ranging from 10 to 30 per 
day). The duration of smoking was more than 10 years in 33 cases where 
as in 5 cases it was less than 10 years.  
Table – 3 
Smoking No. of cases Percentage 
Absent 12 24% 
Present 38 76% 
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Table –4  
Smoking duration No. of cases Percentage 
< 10 Yrs 5 10% 
10-20 Yrs 22 44% 
21-30 Yrs 9 18% 
> 30 Yrs 2 4% 
 
PAST HISTORY OF TUBERCULOSIS: 
 Past history of tuberculosis was present in nine among the 50 
patients. Among them documented sputum positivity and records were 
available with six of them. Six of them completed treatment and three 
defaulted. Five out of the nine were non smokers which accounted for 
more than 50% of them. Only two of them had a history of smoking for 
more than 10 years. 
SYMPTOMATOLOGY: 
 All the patients with corpulmonale had breathlessness and cough. 
Most patients presented with pain abdomen and swelling of feet.  
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 Fever was present in 24% percent of patients whereas loss of 
appetite was in 74 percent, chest pain was noted in 12% and hemoptysis 
in 16 percent. 20 percent of patients presented with palpitation.  
The details about the symptoms are depicted in the table 
Table – 5 
SYMPTOMATOLOGY 
Symptoms No. of cases Percentage 
Breathlessness 50 100 
Cough  with expectoration 50 100 
Pain abdomen  32 64 
Loss of appetite 37 74 
Swelling of feet 44 88 
Fever 12 24 
Haemoptysis 8 16 
Palpitation 10 20 
Chest pain  6 12 
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Physical Findings: 
 All patients had right sided heart failure in the form of raised 
Jugular venous pressure, tender enlarged liver and bilateral pedal edema. 
Most commonly observed physical findings in our study are tachypnoea, 
active accessory respiratory muscles, diminished chest expansion, 
epigasteric heave, crepitations and rhonchi on auscultation and loud 
pulmonic sound.  
Table – 6 
PHYSICAL FINDINGS 
Signs No. of cases Percentage 
Tachycardia 24 48 
Tachypnoea 50 100 
Active accessory respiratory muscles 35 70 
Chest AP diameter equal or greater than 
transverse diameter  
5 10 
Downward displacement of liver dullness 23 46 
Obliteration of cardiac dullness 9 18 
Impalpable apical impulse 11 22 
Epigastric pulsation  17 34 
Parasternal heave 9 18 
Loud pulmonic sound 12 24 
Pansystolic murmur at left lower sternal 
border 
9 18 
Crepitations and / or rhonchi 50 100 
Ascites 5 10 
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 Cardinal signs of right heart failure (pedal edema, palpable tender 
liver and raised jugular venous pressure) was present in all cases.  
RADIOLOGICAL FEATURES: 
 Majority of the X-ray showed Chronic bronchitis with or without 
emphysema, the major etiological factor of chronic corpulmonale. 15 
cases (30%) showed evidence of cardiomegaly, with pulmonary artery 
dilatation. However, the type of chamber enlargement could not be 
accurately predicted in PA view.  
Gross pulmonary fibrosis with are without compensatory 
emphysema was seen in 9 cases. Most the cases had bilateral upper lobe 
involvement. In our X-ray profile, we had one patient with kyphoscoliosis 
with gross thoracic deformity. Six cases (12% ) showed bilateral basal 
bronchiectasis and two cases showed reticulo nodular shadow suggestive 
of interstitial lung disease. CT of the chest was done to confirm the 
diagnosis. 
Radiological features of the lung parenchyma is given in the table 
below. 
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Table – 7 
RADIOLOGICAL FEATURES 
Lung Parenchyma No. of Cases Percentage 
Gross fibrosis with or without  
compensatory emphysema   
9 18 
Increased Broncho vascular markings 
with or without over inflated lung 
fields suggestive of  COPD 
27 54 
Bilateral bronchiectasis  6 12 
Thoracic cage deformity  1 2 
Reticulo nodular pattern 2 4 
Normal  5 10 
 
ELECTROCARDIOGRAM: 
 Among the 50 cases 27 (54%) cases showed evidence of right axis 
deviation, 24 (48%) cases showed low voltage complexes, 14 (28%) 
cases showed P-pulmonale and 10 (20%) cases showed right bundle 
branch block. Eight cases (16%) showed right ventricular hypertrophy. 
Six cases showed other ECG changes viz ventricular ectopics (1 case), T 
inversion in II III AVF (4 cases), sinus tachycardia (1 case). 
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Table – 8 
ECG CHANGES 
ECG Changes No. of cases Percentage 
Right axis deviation 27 54% 
RBBB 10 20% 
P-pulmonale 14 28% 
Low-Voltage 
complexes  
24 48% 
RVH  8 16% 
Other changes 6 12% 
 
CAUSES OF CHRONIC CORPULMONALE: 
 In our study the cause of chronic corpulmonale in majority of the 
cases was chronic bronchitis and emphysema 54%. In nine of the cases 
sequelae of pulmonary tuberculosis was the cause. Five cases had 
bronchial asthma, six cases bronchiectasis one case had kyphoscoliosis 
with thoracic deformity and two had interstitial lung diseases. 
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 Causes of Chronic corpulmonale are shown in table 
Table – 9 
CAUSES OF CHRONIC CORPULMONALE 
Cause No. of Cases Percentage 
Chronic bronchitis / emphysema 27 54 
Bronchial asthma 5 10 
Bronchiectasis  6 12 
Sequelae of pulmonary 
tuberculosis  
9 18 
Kypho-scoliosis with thoracic 
deformity 
1 2 
Interstitial lung disease 2 4 
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DISCUSSION 
   Among 50 patients in our study 20% were found to be females and 
the remaining males. Most of the study population in our present study 
were in the 40 to 60 year age group. The age and sex ratio in our study is 
comparable to the studies done previously35,44. Shankar et al reported a 
similar age distribution in his study.35 
The present study showed that 76% of the patients were smokers as 
compared to 70% reported by Padmavathi et al35 and 80% reported by 
Shankar et al44. The importance of smoking has also been stressed in 
various studies done previously in our country and outside. 
The symptoms and physical findings observed did not vary much 
from studies done previously35,44 
Comparison of electrocardiographic findings in the present study 
and studies done previously are given below 
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Table - 10 
COMPARATIVE PERCENTAGE OF P PULMONALE IN 
DIFFERENT SERIES45 
SERIES PERCENTAGE 
Spodick 1959 13.9% 
Calatayud 1970 46.2% 
Ivan J. Pinto 33.3% 
Chappel 1966 29.% 
Present study 28% 
 
Table - 11 
COMPARITIVE PERCENTAGE OF RIGHT AXIS DEVIATION45 
SERIES PERCENTAGE 
Padmavathi  43.4% 
Pinto 45.5% 
Present study 54% 
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Table - 12 
COMPARITIVE PERCENTAGE OF RBBB45 
SERIES PERCENTAGE 
Padmavathi 7.2% 
Pinto 13.3% 
Present study 20% 
 
Causes of chronic cor pulmonale in our study was COPD in 54%, 
sequelae of pulmonary tuberculosis in 18% and bronchiectasis in 12%. 
The etiological causes in Padmavati et al series44 was chronic bronchitis 
and emphysema in 50.8% of cases. In Kamal et al series chronic 
bronchitis and emphysema was the contributor in 60% of cases. Thus the 
present study and various other studies show that emphysema and chronic 
bronchitis is major etiological factor in the production chronic cor 
pulmonale. 
In studies done recently from United States and United Kingdom 
the cause of cor pulmonale was COPD in 85% of cases9,21. Pulmonary 
tuberculosis was very rarely associated with cor pulmonale. But in our 
study we found an association of 18% with pulmonary tuberculosis, 
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which formed a significant number. It probably reflects the increased 
prevalence of pulmonary tuberculosis in our set up as compared to the 
other parts of the world. 
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SUMMARY 
1. The objective of the study was to know the etiology and clinical 
profile including radiological features and ECG changes in chronic 
corpulmonale.  
2. 50 cases of chronic corpulmonale, of which 40 were males and 10 
were female were included in the study.  
3. Chronic corpulmonale was predominantly found to be a disease of 
middle and older age groups with a peak incidence in the fifth and 
sixth decades.  
4. Smoking plays a significant role in precipitating and aggravating 
the primary lung disease and hence corpulmonale.  
5. Thorough interrogation with reference to symptoms of 
breathlessness, cough with expectoration swelling of the feet etc, 
was done.  
6. Detailed clinical examination was carried out to confirm the 
diagnosis of corpulmonale and to find out any associated evidence 
of lung parenchymatous lesion. Nine cases had sequelae of 
pulmonary tuberculosis Six cases had bilateral bronchiectasis and 5 
cases had bronchial asthma 1 case had kyphoscoliosis and 2 had 
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ILD. The remaining cases were chronic bronchitis with or without 
emphysema.  
7. Chest X-ray was done in all cases. Chest X-ray showed details of 
relevant clinical profile. Thus the changes included chronic 
bronchitis with or without emphysema (54%), braonchiectasis 
(12%). Bilateral pulmonary tuberculosis with fibrosis with or 
without compensatory emphysema (18%). One case (2%) showed 
kyphoscoliosis with gross thoracic deformity. Two (4%) had 
reticulo nodular pattern suggestive  of ILD. CT scan was done in 
necessary cases.  
8. In all the clinically proved cases of corpulmonale Electro 
cardiogram was recorded in all the 12 leads along with V3R, V4R. 
It was recorded at a speed of 25 mm/sec with standardization of 1 
mv – 10 mm. 
9. ECG varies between normal (only sinus tachycardia) to evidece of 
dominant right ventricular activity. The latter was evidenced by 
RVH (16%). Righ Axis deviation (54%) RBBB (20%) and P – 
Pulmonale (28%). One case had ventricular ectopics.  
10. Response to treatment was better in patients with symptoms of 
lesser duration compared to patients with symptoms of longer 
duration.  
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CONCLUSION 
The major cause of chronic cor pulmonale in our study was found 
to be Chronic Obstructive Pulmonary Disease followed by sequelae of 
pulmonary tuberculosis. Smoking formed the  major and most important 
causal association in the present study.                                                                                
 
 
PROFORMA 
 
I. General information about the patient: 
Name:    Date of Admission: 
Age:     Date of Discharge:  
Sex:    I.P. No: 
Occupation & Income:   
II. Complaints with duration:  
 1. Cough with expectoration and nature of the sputum:  
  a. Duration  
  b. Quantity:    e. Smell: 
  c.  Quality:    f. Relation to posture: 
  d.  Colour:  
 2. Breathlessness 
a. At rest:  
b. On exertion: 
c. Constant or paroxysms:  
d. Relation to posture: 
 3. Swelling 
a. Extremities: 
b. Face: 
c. Abdomen: 
4.  Fever: 
5. Chest pain:  
6. Haemoptysis:  
7. Palpitation: 
8. Headache:  
2.  Drowsiness: 
3.  Abdominal pain:  
4.  Fatigue: 
5.  Scanty urine: 
III. History of present illness: 
 The mode of onset and appearance of symptoms in chronological order 
with their duration.  
IV.  History of previous illness: 
 a. Chronic bronchitis   f. Pneumoconiosis  
 b. Bronchial asthma    g. Thoracic operations 
 c. Any suppurative lung disorders  h. Malignancy with details 
 d. Tuberculosis and its treatment details  
 e. Any other disease, listed under classification.  
V.  Family History: 
 Parents    Sisters 
 Brothers    Children 
VI.  Personal History: 
 a. Appetite   d. Bowels  
 b. Sleep   e. Smoking & alcohal  
 c. Micturation  f. Menstruation  
VII. Clinical examination  
 A. General physical examination: 
  1. Body built   10. Abdominal distension  
  2. State  of nutrition  11. Jaundice 
  3. Pallor    12. Peripheral lymphadenopthy  
  4. Cyanosis    13. Temperature  
  5. Clubbing    14. State of consciousness  
  6. Coldness or warmth of the extremities  
  7. B.P.   15. Edema  
  8. Distended peripheral veins Jugular venous pressure : 'a' and 'v' 
      waves.  
  9. Pulse : Rate, Rhythm, Volume, State of arterial vessels wall  
       and character of the pulse.  
B. Cardiovascular system: 
 a. Inspection: 1. Apical impulse   3. Epigastric pulsation  
   2. Parasternal heave  4.  Any other abnormalities  
 b. Palption:      Nature of the special impulse, thrill etc.  
 c. Percussion:    Cardiac dullness 
       Dullness over the lower end of sternum  
 d. Auscultation:  3rd Heart sound   P2 splitting 
        P2 accentuation   Any murmurs 
C. Respiratory system: 
 a. Inspection:      Shape of chest   Any other deformities  
         Tracheal position Rate & Type of  respiration 
         Kyphoscoliosis     
 b. Palpation:        Tracheal position Apex beat 
         Movements   Measurement of chest  
 c. Percussion:  
 d. Auscultation: Breath sound, Adventitious sounds  
D. Abdomen: 
 Inspection, Palpation, Percussion & Auscultation 
E. Central Nervous System: 
 HMF, Cr, nerves, Motor & Reflexes, Sensory, Cerebellar, skull & spine, 
Meningeal signs.  
 
VIII. Electro cardiogram  
 a. Rate:  
a. Rhythm 
b. Voltage 
c. Axis  
d. P – Pulmonale  
e. Presence of ventricular hypertrophy  
f. Presence of RBBB 
g. Other changes 
IX. Chest X-ray 
 a.  Lung parenchyma  
 b. Cardiac shadow  
 c. Pulmonary Artery  
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Diseases leading to 
corpulmonale 
1 65/M Agri 15 4 Y 2 Y 10 Y emph+card. + - - + - T-II III aVF C.B.+EMP. 
2 35/M  Agri 10 2 Y 3 M 3 Y Card+mpa enlarg_PAH - - + - - T-II III aVF BR.asthma 
3 38/M Cooli 8 2 Y 6 M 3 Y Bil.Fibro p.kochs+empy + - + - - - Bil.pulkochs+emph 
4 55/M Agri 10 20 Y 10 Y 10 Y INC.br.mark,sugg,ch,bronch + - - + - - C.B 
5 68/M Agri 10 20 Y 1 Y 20 Y Bil basalbronch+emph+MPA promi + - + - + - Bil. bronchiectasis 
6 65/M Agri 20 10 Y 5 Y 7 Y Cardi. MPA promi +emph + - - - + - Ch bronch+emph 
7 58/M Clerk 24 2 Y 2 Y 8 Y Emph + card + promi MPA - + + + - - C.B +emph 
8 80/M Busi - 4 Y 5 M 4 Y Bil.fibro p.kokhs+emph + + - - - - Bil.P.Kochs+emph 
9 54/M H.Serv 15 4 Y 1 M 15 Y Card+ccf + + - - - - Br.asthama 
10 50/M Driver 32 4 Y 4 Y 12 Y Card+emph+MPA, promi + - - + + - C.B.+emph 
11 37/M Mason 17 3 Y 6 M 5 Y Card+Rvconf, P.conus prom, MPA 
+ emph  
+ - + + - - C.B.+emph 
12 85/M Teacher 20 6 Y 8 M 8 Y Bil. EMPH - - + - + - C.B.+emph 
13 70/M Tailor 25 8 Y 1 Y 3 Y Emp+tub heart - + + - - - C.B.+emph 
14 45/F H.W. - 15 Y 3 Y 6 Y Card+MPA prom + + - - - - Br.Asthma 
15 55/M Worker 15 2 Y 5 M 5 Y Bil.EMPH + - - - + - C.B+emph 
16 38/M Clerk 18 16 Y 6 M 10 Y Normal - + - - - - Br.asthma 
17 50/F H.W. - 15 Y 3 Y 8 Y Card+RNP + - + - - - ILD 
18 80/M Agri 35 10 Y 3 Y 8 Y Bil EMPH+tub heart - + - + - S.Tachy CB+emph 
19 55/F Worker - 5 Y 3 M 8 Y Rt basal bronchiactasis - + - + - Vent ectopic Bil.Bronchiectasis 
20 35/F H.W. - 3 Y 2 M 5 Y Bil basal bronchiactasis - - - - - - Bil.Bronchiectasis 
21 35/M Weaver 18 8 Y 2 Y 3 Y  Bil emph+low set diaph - - - - - - C.B.+ emph 
22 42/F H.W - 2 Y 4 M 2 Y Bil emph + promi MPA - + - - - - C.B.+ emph 
23 55/M Agri 20 5 Y 2 M 3 Y Rt basal bronch + + - - - - Bronchiectasis 
24 48/M Sh.keep 20  8 Y 2 Y 5 Y Kyp sco. + eventr. diaph+CCF + - - + + - Kyphsco+grossthorac.defor 
25 40/M Busi. 8 2 Y 1 M 2 Y Bil. emph - + - - - T-II III aVF C.B + emph 
26 55/M Worker 15 5Y 3M 5Y Bil.emph + tub heart - + - - - - C.B. + emph 
27 35/F Cooli - 2Y 6M 2Y Cav, rt & It uz + cal, spots - - + - - - Bil p.kochs 
28 45/M Teacher 15 6Y 2Y 8Y Bil. emph + MPA promi - + - - - - C.B. + emph 
29 60/F Servent - 14Y 6M 10Y Card+ bil fibrosis - + - - - - BL Old P.Kochs. 
30 53/M Agri - 8Y 6M 8Y Card + uz kokhs + + - - - - BL Old P.Kochs. 
31 44/M Cooli 8 8Y 2M 8Y Card + uz kokhs - - + + - - Pul Kochs + emph 
32 48/M Mech 8 5M 4M 6Y inc Bronch vasc marker  - + - - - - C.B.  
33 38/M Mason 7 3Y 8M 5Y Bil.emph + - - - - - C.B. + emph 
34 49/F Servent - 6Y 1Y 8Y Bil.uz.kochs + cav. Rt.mz+emph + + + - - - Bil.p.kochs+emph 
35 52/M Vendor 22 2Y 8M 6Y Bil.emph+tub heart - + - - - - C.B. + emph  
36 64/M Agri 24 6Y 8M 8Y Bil.emph - + - - - - C.B. +emph 
37 53/M Tailor 14 3Y 2M 4Y Bil fibro pul kochs + - - - - - Bil. p. kochs + emph 
38. 57/M Driver 27 4Y 4M 6Y Emph. + mpa promi + - + - - - C.B. + emph 
39. 55/M Worker 16 6Y 2M 8Y Bil.emph - + - - - - C.B. + emph 
40. 59/M Agri 18 8Y 1Y 10Y Bil emph+mpa promi + - - - + - C.B+emph 
41. 50/M Cooli 20 4 Y 6 M 4 Y Bil.uz kochs+cav.Rt.mz+emph + + + - - - Bil.p. kochs+emph 
42. 44/M Driver 15 6 Y 8 M 5 Y Bil. emph + - + - - - C.B. + emph 
43. 35/F H.W - 3 Y 2 M 2 Y RNP+Card + PAD - + - - - - ILD 
44. 64/M Mil Work 22 8 Y 9 M 6 Y Rt. Basal. bronch + + - - - - Bronchiectasis 
45. 65/F Cooli - 2 Y 1 M 4 Y Bil. emph + - - - - T-II III aVF C.B. + emph 
46. 54/M Mason 18 10 Y 2 M 6 Y Bil emph + + - - - - emph 
47. 58/M Cooli 16 8 Y 1 M 8 Y Normal + - - - - - Br. asthma 
48. 56/M Servent 22 2 Y 6 M 2 Y Card+rv conf. P. conus prom+ emph + - + - - - C.B. + emph 
49. 38/M Agri 12 10 Y 3 M 12 M Bil. emph + lowset diaph - - - - - - Vent. ectopic+C.B. emph 
50. 70/M Agri 23 6 Y 8 M 4 Y Rt. Basal. bronchiactasis - - - - + - Bil. bronchiectasis 
ABBREVIATIONS 
 Bil  - Bilateral 
 Rt  - Right  
 Cal  - Calcified 
 LZ  - Lower zone 
 Emph  - Emphysema 
 Card  - Cardiomegaly 
 MPA  - Main pulmonary artery 
 Enlarge - Enlarged 
 P. Koch's  - Pulmonary Koch's 
 Inc  - Increased 
 Broncho - Bronchovascular 
 Mark  - Markings 
 Sugg  - Suggestive 
 MZ  - Midzone 
 Hil  - Hilar 
 Promi  - Prominent 
 Cardiomeg - Cardiomegaly 
 CCF  - Congestive cardiac failure 
 RNP   - Recticulonodular pattern     
 RV Conf. - Right ventricular configuration 
 Br. Asthma - Bronchial asthma 
 P. Conus - Pulmonary conus 
 Dia  - Diaphragm  
 Vent Ect - Ventricular ectopics 
 S. Tachy - Sinus tachycardia 
 Fibro  - Fibrosis 
 ILD  - Interstrial lung disease 
 
